SC Filed 2019-02-13 Event — SEC 0001193125-19-037699 →

EW Healthcare Partners, L.P. → EyePoint Pharmaceuticals, Inc. EYPT

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 21/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (8.1 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 8.07

21,260,757 shares short · +2.3% vs prior

Other 13D/G Filings on EyePoint Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-09-08	SCHEDULE 13G	Janus Henderson Group Ltd.	—	—	view →
2026-06-03	SCHEDULE 13G	Commodore Capital LP	—	—	view →
2018-07-05	SC	EW Healthcare Partners, L.P.	—	—	view →

Other Filings by EW Healthcare Partners, L.P.

Filed	Form	Issuer	Stake	Shares
2026-04-01	SCHEDULE 13D/A	Venus Concept, Inc.	—	0	view →
2023-07-14	SC	Venus Concept Inc.	—	—	view →
2023-05-24	SC	Venus Concept Inc.	—	—	view →
2022-11-28	SC	Venus Concept Inc.	—	—	view →
2022-02-03	SC	Venus Concept Inc.	—	—	view →
2021-02-12	SC	Venus Concept Inc.	—	—	view →
2020-03-31	SC	Venus Concept Inc.	—	—	view →
2018-07-05	SC	EyePoint Pharmaceuticals, Inc. EYPT	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →